MKN-74 Cells
CAD$897.00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
General information
| Description | The MKN-74 cell line is derived from human gastric carcinoma and is part of the MKN series of cell lines, which were developed to study various aspects of gastric cancer. Specifically, MKN-74 was established from a poorly differentiated adenocarcinoma of the stomach, a type of gastric cancer known for its aggressive nature and poor prognosis. This cell line is particularly useful for research focused on understanding the molecular mechanisms driving tumor progression, invasion, and metastasis in poorly differentiated gastric cancers. MKN-74 cells exhibit an epithelial morphology and are known to grow in monolayers. They are characterized by their high proliferative capacity and ability to form colonies in soft agar, indicating a strong anchorage-independent growth potential, a hallmark of malignancy. This cell line is also valuable for studying the signaling pathways involved in gastric cancer, particularly those related to cell proliferation, survival, and resistance to chemotherapy. Additionally, MKN-74 cells have been used in xenograft models to investigate tumor growth and response to therapeutic agents, making them an important tool in preclinical drug development and cancer research. |
|---|---|
| Organism | Human |
| Tissue | Stomach |
| Disease | Gastric tubular adenocarcinoma |
| Metastatic site | Liver |
| Synonyms | MKN74, MKN 74 |
Characteristics
| Age | 62 years |
|---|---|
| Gender | Male |
| Ethnicity | East Asian |
| Growth properties | Adherent |
Regulatory Data
| Citation | MKN-74 (Cytion catalog number 300490) |
|---|---|
| NCBI_TaxID | 9606 |
| CellosaurusAccession | CVCL_2791 |
Biomolecular Data
Handling
| Culture Medium | RPMI 1640, w: 2.0 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a) |
|---|---|
| Supplements | Supplement the medium with 10% FBS |
| Dissociation Reagent | Accutase |
| Subculturing | Remove the old medium from the adherent cells and wash them with PBS that lacks calcium and magnesium. For T25 flasks, use 3-5 ml of PBS, and for T75 flasks, use 5-10 ml. Then, cover the cells completely with Accutase, using 1-2 ml for T25 flasks and 2.5 ml for T75 flasks. Let the cells incubate at room temperature for 8-10 minutes to detach them. After incubation, gently mix the cells with 10 ml of medium to resuspend them, then centrifuge at 300xg for 3 minutes. Discard the supernatant, resuspend the cells in fresh medium, and transfer them into new flasks that already contain fresh medium. |
| Freeze medium | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Thawing and Culturing Cells |
|
| Incubation Atmosphere | 37°C, 5% CO2, humidified atmosphere. |
| Shipping Conditions | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Storage Conditions | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Quality Control & Molecular Analysis
| Sterility | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
Certificate of Analysis (CoA)
| Lot Number | Certificate Type | Date | Catalog Number |
|---|---|---|---|
| 300490-111225 | Certificate of Analysis | 27. Jan. 2026 | 300490 |
| 300490-110923 | Certificate of Analysis | 23. May. 2025 | 300490 |